Description
The role of direct oral anticoagulants in the management of cancer-associated thrombosis
- You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart
Article: The role of direct oral anticoagulants in the management of cancer-associated thrombosis
€3.03
